ArticleChemSusChem2019
Nickel-Catalyzed Stereodivergent Synthesis of E- and Z-Alkenes by Hydrogenation of Alkynes.
Article in ChemSusChem, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Modular synthesis of trisubstituted olefins and 1,3-dienes from renewable alcohols via ligand-enabled nickel catalysis.Nature communications · 2026Article
- Nickel/Photoredox-catalyzed diastereoselective semihydrogenation of alkynes using a carboxylic acid as a cooperative ligand and hydrogen surrogate.Nature communications · 2026Article
- One-Electron Approach for Trans-Selective Alkyne Semi-Reduction via Cobalt Catalysis.Journal of the American Chemical Society · 2025Article
- The stereo-divergent functionalization of alkynes: a comprehensive review.RSC advances · 2025Review
- Stereodivergent Palladium-Catalyzed C-F Bond Functionalization ofOrganic letters · 2024Article
- Cooperative HNature chemistry · 2024Article
- Modulation of metal species as control point for Ni-catalyzed stereodivergent semihydrogenation of alkynes with water.Nature communications · 2023Article
- Chromium-catalyzed stereodivergent E- and Z-selective alkyne hydrogenation controlled by cyclic (alkyl)(amino)carbene ligands.Nature communications · 2023Article
- E-selective Semi-hydrogenation of Alkynes under Mild Conditions by a Diruthenium Hydride Complex.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022Article
- Stereoselective Semi-Hydrogenations of Alkynes by First-Row (3d) Transition Metal Catalysts.ChemCatChem · 2022Review
- Mechanistic Investigations on Hydrogenation, Isomerization and Hydrosilylation Reactions Mediated by a Germyl-Rhodium System.ChemCatChem · 2022Article
- Controlled Selectivity through Reversible Inhibition of the Catalyst: Stereodivergent Semihydrogenation of Alkynes.Journal of the American Chemical Society · 2022Article
- Low-Valent Molybdenum PNP Pincer Complexes as Catalysts for the Semihydrogenation of Alkynes.Organometallics · 2022Article
- Article
- Article
- Four- and five-coordinate nickel(ii) complexes bearing new diphosphine-phosphonite and triphosphine-phosphite ligands: catalysts forRSC advances · 2022Article
- Electrochemical Proton Reduction over Nickel Foam for Z-Stereoselective Semihydrogenation/deuteration of Functionalized Alkynes.ChemSusChem · 2022Article
- Selective hydrogenation of diphenylacetylene using NiCo nanoparticles supported on mesoporous carbon as catalyst.Turkish journal of chemistry · 2022Article
- General and selective synthesis of primary amines using Ni-based homogeneous catalysts.Chemical science · 2020Article
- A Simple Nickel Catalyst Enabling an E-Selective Alkyne Semihydrogenation.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A convenient protocol for stereodivergent hydrogenation of alkynes to E- and Z-alkenes by using nickel catalysts was developed. Simple Ni(NO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.